{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:59:24Z","timestamp":1648886364732},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s40618-014-0224-0","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T07:34:07Z","timestamp":1418283247000},"page":"541-546","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family"],"prefix":"10.1007","volume":"38","author":[{"given":"M. N.","family":"Basaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Tuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Karak\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. A.","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. N.","family":"\u0130mga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Berker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"224_CR1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565\u2013612","journal-title":"Thyroid"},{"key":"224_CR2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.1995.5.407","volume":"5","author":"DJ Marsh","year":"1995","unstructured":"Marsh DJ, Learoyd DL, Robinson BG (1995) Medullary thyroid carcinoma: recent advances and management update. Thyroid 5:407\u2013424","journal-title":"Thyroid"},{"key":"224_CR3","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","volume":"98","author":"SA Wells Jr","year":"2013","unstructured":"Wells SA Jr, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab 98:3149\u20133164","journal-title":"J Clin Endocrinol Metab"},{"key":"224_CR4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/jc.2013-3343","volume":"99","author":"A Machens","year":"2014","unstructured":"Machens A, Lorenz K, Dralle H (2014) Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations. J Clin Endocrinol Metab 99:286\u2013292","journal-title":"J Clin Endocrinol Metab"},{"key":"224_CR5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167\u20131214","journal-title":"Thyroid"},{"key":"224_CR6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471\u20131474","journal-title":"Ann Surg Oncol"},{"key":"224_CR7","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/cncr.28661","volume":"120","author":"GW Krampitz","year":"2014","unstructured":"Krampitz GW, Norton JA (2014) RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer 120:1920\u20131931","journal-title":"Cancer"},{"key":"224_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ecl.2008.02.006","volume":"37","author":"MD Castellone","year":"2008","unstructured":"Castellone MD, Santoro M (2008) Dysregulated RET signaling in thyroid cancer. Endocrinol Metab Clin North Am 37:363\u2013374","journal-title":"Endocrinol Metab Clin North Am"},{"key":"224_CR9","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.surg.2010.09.004","volume":"148","author":"AL Shifrin","year":"2010","unstructured":"Shifrin AL, Ogilvie JB, Stang MT et al (2010) Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary\/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation. Surgery 148:1274\u20131280","journal-title":"Surgery"},{"key":"224_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","volume":"93","author":"R Elisei","year":"2008","unstructured":"Elisei R, Cosci B, Romei C et al (2008) Prognostic significance of somatic RET proto-oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682\u2013687","journal-title":"J Clin Endocrinol Metab"},{"key":"224_CR11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J et al (2003) Early malignant progression of hereditary medullary thyroid carcinoma. N Engl J Med 349:1517\u20131525","journal-title":"N Engl J Med"},{"key":"224_CR12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7","volume":"69","author":"M Fink","year":"1996","unstructured":"Fink M, Weinh\u20acusel A, Niederle B, Haas OA (1996) Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. \u2018\u2018Study Group Multiple Endocrine Neoplasia Austria (SMENA)\u2019\u2019. Int J Cancer 69:312\u2013316","journal-title":"Int J Cancer"},{"key":"224_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","volume":"128","author":"GL Feldman","year":"2000","unstructured":"Feldman GL, Edmonds MW, Ainsworth PJ et al (2000) Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG\u2013>ATG) mutation. Surgery 128:93\u201398","journal-title":"Surgery"},{"key":"224_CR14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.surg.2009.09.021","volume":"146","author":"A Shifrin","year":"2009","unstructured":"Shifrin A, Xenachis Cristina, Fay Angela et al (2009) One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome\u2014MEN 2C? Surgery 146:998\u20131005","journal-title":"Surgery"},{"key":"224_CR15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2005.02394.x","volume":"63","author":"DL Learoyd","year":"2005","unstructured":"Learoyd DL, Gosnell J, Elston MS et al (2005) Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clin Endocrinol (Oxf) 63:636\u2013641","journal-title":"Clin Endocrinol (Oxf)"},{"key":"224_CR16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/105072502320288393","volume":"12","author":"M Brauckhoff","year":"2002","unstructured":"Brauckhoff M, Gimm O, Hinze R, Ukkat J, Brauckhoff K, Dralle H (2002) Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation. Thyroid 12:557\u2013561","journal-title":"Thyroid"},{"key":"224_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1752-1947-1-133","volume":"1","author":"G Dionigi","year":"2007","unstructured":"Dionigi G, Castano P, Bertolini V et al (2007) Simultaneous medullary and papillary thyroid cancer: two case reports. J Med Case Reports 1:133","journal-title":"J Med Case Reports"},{"key":"224_CR18","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/ijc.27967","volume":"132","author":"F Lantieri","year":"2013","unstructured":"Lantieri F, Caroli F, Ceccherini I, Griseri P (2013) The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study. Int J Cancer 132:2808\u20132819","journal-title":"Int J Cancer"},{"key":"224_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrrev.2012.09.002","volume":"752","author":"G Figlioli","year":"2013","unstructured":"Figlioli G, Landi S, Romei C, Elisei R, Gemignani F (2013) Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat Res 752:36\u201344","journal-title":"Mutat Res"},{"key":"224_CR20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jmg.39.4.260","volume":"39","author":"F Lesueur","year":"2002","unstructured":"Lesueur F, Corbex M, McKay JD, Lima J, Soares P et al (2002) Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet 39:260\u2013265","journal-title":"J Med Genet"},{"key":"224_CR21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1055-9965.EPI-06-0665","volume":"16","author":"S Lonn","year":"2007","unstructured":"Lonn S, Bhatti P, Alexander BH, Pineda MA, Doody MM et al (2007) Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev 16:174\u2013177","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"224_CR22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/msy.2002.123006","volume":"131","author":"A Lecube","year":"2002","unstructured":"Lecube A, Hernandez C, Oriola J et al (2002) V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers. Surgery 131:509\u2013514","journal-title":"Surgery"},{"issue":"10","key":"224_CR23","doi-asserted-by":"crossref","first-page":"e109822","DOI":"10.1371\/journal.pone.0109822","volume":"9","author":"M Santos","year":"2014","unstructured":"Santos M, Azevedo T, Martins T, Rodrigues FJ, Lemos MC (2014) Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the portuguese population: a case-control study. PLoS One 9(10):e109822","journal-title":"PLoS One"},{"key":"224_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.2007.02830.x","volume":"67","author":"M Recasens","year":"2007","unstructured":"Recasens M, Oriola J, Fern\u00e1ndez-Real JM et al (2007) Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene. Clin Endocrinol (Oxf) 67:29\u201333","journal-title":"Clin Endocrinol (Oxf)"},{"key":"224_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","volume":"128","author":"GL Feldman","year":"2000","unstructured":"Feldman GL, Edmonds MW, Ainsworth PJ, Schuffenecker I, Lenoir GM, Saxe AW, Talpos GB, Roberson J, Petrucelli N, Jackson CE (2000) Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG\u2013>ATG) mutation. Surgery 128:93\u201398","journal-title":"Surgery"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0224-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0224-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0224-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T06:12:05Z","timestamp":1566108725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0224-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0224-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}